baber/WOPTO huggingface dataset:
Patent NZ-336274-A (NZ)
Title: Antiperspirant or deodorant composition comprising a moisturising cream containing a humectant
Inventor: ESSER ISABELLE CLAIRE HELENE M
IPC: A61K8/34
Filed: 1997-12-03
Abstract: An anhydrous stick antiperspirant or deodorant composition includes an antiperspirant or deodorant active, a carrier for the active and a moisturising cream.  The moisturizing cream includes one or more humectants including at least one hydroxyl group and a perfume carrier material.
Patent NZ-500351-A (NZ)
Title: Cyclic diaza compounds as selective factor Xa inhibitors
Inventor: SCARBOROUGH ROBERT M
IPC: A61P9/00
Filed: 1998-04-13
Abstract: Compounds of the given formula suitable for treating conditions characterized by undesired thrombosis, unstable angina, refractory angina, myocardial infarction, transient ischemic attacks, thrombotic stroke, embolic stroke, disseminated intravascular coagulation, septic shock, deep venous thrombosis, pulmonary embolism, or reocclusion or restenosis of reperfused coronary arteries
Patent NZ-500503-A (NZ)
Title: Heat exchanger for air conditioning system with thermoelectric units sandwiched between heat exchanger elements having tortuous paths
Inventor: BRYRUP NIELS POUL
IPC: F28F3/12
Filed: 1999-10-20
Abstract: Heat exchanger 10 has first and second heat exchange elements 11,12 each with respective inlet 14 and outlet 15. Thermoelectric units (typically Peltier elements) 17 are located side by side and clamped between elements 11,12. Flow passages in the elements 11,12 are formed by sheet metal inserts  arranged in cavities in the elements (not shown).
Patent NZ-508421-A (NZ)
Title: Crop protection formulations with delayed release of active ingredient
Inventor: ERNST ANDREAS
IPC: A01N63/00
Filed: 1999-04-22
Abstract: A solid formulation of a crop protection product with delayed release of the active ingredient, obtained by melting together a composition comprising 0.1-80% by weight of said (crop protection) active ingredient, 10-80% by weight of a mineral filler, 0-20% by weight of an inorganic or organic additive, and to 100% by weight of polybutylene adipate terephthalate.
Patent NZ-509025-A (NZ)
Title: C-terminal modified oxamyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases
Inventor: KARANEWSKY DONALD S
IPC: A61K31/16
Filed: 1999-07-01
Abstract: Oxamyl dipeptide ICE/ced-3 family inhibitor compounds of formula (I), pharmaceutical compositions containing these compounds, as well as to the use of such compositions in the treatment of patients suffering inflammatory, autoimmune and neurodegenerative diseases, for the prevention of ischemic injury, and for the preservation of organs that are to undergo a transplantation procedure are disclosed, wherein the variables R1, R2, A and B are as defined in the specification.
Patent NZ-511091-A (NZ)
Title: New cyclobutaindolecarboxamide compounds, a process for their preparation and pharmaceutical compositions containing them
Inventor: PEGLION JEAN-LOUIS
IPC: A61P25/00
Filed: 2001-04-12
Abstract: Compounds of formula (I) wherein: N is 0 to 6; R1 is selected from hydrogen, hydroxy, cyano, linear or branched (C1-C6)alkoxy, linear or branched (C1-C6)alkoxycarbonyl, carboxy, aminocarbonyl (the aminomoiety optionally being substituted by one or two identical or different groups selected from linear or branched (C1-C6)alkyl, aryl and aryl(C1-C6)alkyl in which the alkyl moiety may be linear or branched) and NR4R5 wherein R4 and R5, which may be identical or different, selected from linear or branched (C1-C6)alkyl, aryl, aryl(C1-C6)alkyl in which the alkyl moiety may be linear or branched, heteroaryl, heteroaryl(C1-C6)alkyl in which the alkyl moiety may be linear or branched, cycloalkyl, cycloalkyl(C1-C6)alkyl in which the alkyl moiety is linear or branched, linear or branched (C2-C6)alkenyl and linear or branched (C2-C6)alkynyl, R2 represents hydrogen, linear or branched (C1-C6)alkyl, hydroxymethyl, a group of formula (II) wherein: T represents a monocyclic or polycyclic (C3-C12)cyclolkyl group, it being possible for one of the carbon atoms of the cycloalkyl optionally to be replaced by a group selected from O, Se, a group of formula S(O)p wherein p is 0-2, and a group of formula SiR6R7 wherein R6 and R7, which may be identical or different, represent a linear or branched (C1-C6)alkyl group,; U is a bond or methylene group; V is a bond, O or S(O)q wherein q is 0-2, and W is selected from aryl, aryl(C1-C6)alkyl in which the alkyl moiety may be linear or branched, cycloalkyl, and cycloalkyl(C1-C6)alkyl in which the alkyl moiety may be linear or branched; and R3 is selected from hydrogen linear or branched (C1-C6)alkyl, aryl and heteroaryl. The compounds are useful in the treatment of disorders of the central nervous system, such as anxiety, panic attacks, obsessive-compulsive disorders, phobias, impulsive disorders, drug abuse, cognitive disorders, psychoses, depression and mood disorders.
Patent NZ-514937-A (NZ)
Title: Disinfecting composition based on hydrogen peroxide, acids and metal ions; used for surface treatment or stripping
Inventor: WILMOTTE REMI
IPC: A61K33/24
Filed: 2000-04-25
Abstract: Described are oxidising aqueous composition useful for disinfection, hygiene and anti-pollution purposes, and for surface treatment (particularly a metal surface to be stripped and/or passivated). The composition, containing in water, hydrogen peroxide, a RCO2H/RCO3H mixture (wherein R is a C1-C6 aliphatic radical with a linear or branched hydrocarbon chain, saturated or unsaturated), a stabilising agent which is an acid and, as the case may be, Ag+ ions. It contains ions of at least one metal M, which can be ions of AgII, AgIII, VV, NbV, TaV, MoVI, WVI, CoIII, InIII or TllII. The composition can be in gel form. The method for preparing the composition is also described.
Patent NZ-516237-A (NZ)
Title: Meth1 and meth2 polynucleotides and polypeptides
Inventor: HASTINGS GREGG A
IPC: C07K19/00
Filed: 2000-05-25
Abstract: Isolated nucleic acid molecules are provided encoding human METH1 and METH2, anti-angiogenic proteins, related to thrombospondin. METH1 and METH2 polypeptides are also provided, as are vectors, host cells and recombinant methods for producing the same. Also provided are diagnostic methods for the prognosis of cancer and the use of METH1 and METH2 in the manufacture of medicaments for therapeutically treating individuals in need of an increased amount of METH1 and METH2 and for inhibiting angiogenesis.
Patent NZ-518344-A (NZ)
Title: Container closure system
Inventor: PITASSI JAMES L
IPC: B65D41/18
Filed: 2000-09-13
Abstract: A container closure comprising a cap (2) having a skirt (4) of substantially rectangular cross-section is provided. Disposed in a central location of each internal surface of the skirt are substantially coplanar rim-engaging members. The container (3) has a neck portion (12) terminating in an outer peripheral rim (8) surrounding an oval-shaped opening (7) in one end of the container. Cap-engaging portions on the outer portion of the peripheral rim engage with the rim-engaging members disposed on the skirt internal surface when the cap is in a closed position over the container opening. The rim-engaging members can be in the form of small ridges or grooves and can engage with cap-engaging portions formed by small ribs. Alternatively, when in the form of small ridges, rim-engaging members can engage with cap-engaging portions in the form of a small edge extension around the outer portion of the peripheral rim. The cap may be placed into a closed position on the container by aligning the edge of the skirt with a similarly configured edge of the container body and "snapping" the rim-engaging members on the skirt into an engaged relationship with the cap-engaging portions on the peripheral rim. Twisting the cap slightly with respect to a vertical axis of the container disengages the rim-engaging members and the cap-engaging portions to release the cap to an open position for removal from the container.
Patent NZ-519567-A (NZ)
Title: Glass washer and chiller
Inventor: GOTFRIED BRADLEY L
IPC: B08B9/093
Filed: 2000-12-14
Abstract: An apparatus for washing glasses, including a washing compartment and a plurality of fluid outlets (82). A tray (100) for retaining the glasses is positionable in the washing compartment. The tray (100) has at least one fluid directing nozzle (140) which is alignable with the fluid outlets (82) in the washing compartment to permit fluid to flow from the nozzles (140) through the tray (100) and to direct the fluid into contact with the glasses (146). In preferred embodiment, at least a portion of the fluid contacts the glasses (146) substantially tangentially. A method for washing glasses (146) is also disclosed.
Patent NZ-520547-A (NZ)
Title: A CD25 binding molecule which comprises at least one antigen binding site comprising at least one domain which comprises in sequence, the hypervariable regions CDR1, CDR2 and CDR3
Inventor: ADAM HANSJOERG
IPC: A61K39/395
Filed: 2001-03-28
Abstract: Described is the use of CD25 binding molecule which comprises at least one antigen binding site comprising at least one domain which comprises in sequence, the hypervariable regions CDR1, CDR2 and CDR3; said CDR1 having the amino acid sequence Arg-Tyr-Trp-Met-His; the CDR2 having the amino acid sequence Ala-Ile-Tyr-Pro-Gly-Asn-Ser-Asp-Thr-Ser-Tyr-Asn-Gln-Lys-Phe-Glu-Gly, and the CDR3 having the amino acid sequence Asp-Tyr-Gly-Tyr-Tyr-Phe-Asp-Phe, in the treatment of inflammatory disease of the gastro-intestinal tract.
Patent NZ-521314-A (NZ)
Title: Crystalline form II of carbergoline
Inventor: TOMASI ATTILIO
IPC: C07D457/06
Filed: 2001-03-19
Abstract: Crystalline form II of cabergoline, a pharmaceutical composition containing it and a process for its preparation are disclosed. The process may comprise crystallization from a solution of raw cabergoline in an organic solvent at low temperatures or submitting to a slurry procedure a mixture of cabergoline Forms I and II in a solvent at a temperature below about 30 °C.
Patent NZ-523622-A (NZ)
Title: Stainless steel substrate treatment by reducing the interfacial resistance associated with the stainless steel with an anodic treatment
Inventor: HODGSON DAVID RONALD
IPC: H01M8/02
Filed: 2001-07-24
Abstract: Described are stainless steel components used in electrochemical cells, e.g. fuel cells that are treated by an electrochemical and/or chemical oxidation treatment such as cyclic voltammetry to modify the surface characteristics. The characteristics modified include surface composition and/or morphology. The modification reduces the interfacial resistance associated with the surface of the component thereby.
Patent NZ-527011-A (NZ)
Title: Method of treating of demyelinating diseases or conditions
Inventor: SMITH CRAIG P
IPC: C07D401/12
Filed: 2002-02-14
Abstract: N-(Pyridinyl)-1H-indol-1-amines of formula I provide a unique combination of blocking properties for both the potassium and sodium channels. These compounds are useful for the treatment of Demyelinating Diseases and Conditions such as Multiple Sclerosis, Spinal Cord Injury, Traumatic Brain Injury and Stroke. The compounds are also useful for Stroke Rehabilitation, the treatment of Bladder Irritation and Dysfunction, and the treatment of Neuropathic Pain and Chemokine-Induced Pain.
Patent NZ-533637-A (NZ)
Title: Process for the preparation of concentrated milks and milk powders
Inventor: BERROCAL RAFAEL
IPC: A23C1/12
Filed: 2002-09-24
Abstract: Disclosed is a process for the production of a fat-containing concentrated milk or milk powder, comprising preparing a liquid homogenised milk, adding a negatively charged or non-ionic emulsifier, feeding the mixture into an evaporator having at least one stage to obtain a concentrate having a total solids content of at least 50 %, whereby the emulsifier is added prior or during concentration and then optionally spray drying the concentrate to obtain a powder.
Patent NZ-535182-A (NZ)
Title: 10-(3-cyclopropylaminomethyl-1-pyrrolidinyl) pyridobenzoxazinecarboxylic acid derivative effective against resistant bacterium
Inventor: ASAHINA YOSHIKAZU
IPC: C07D498/06
Filed: 2003-03-13
Abstract: Disclosed are pyridobenzoxazine carboxylic acid derivatives of formula (I), wherein: R1 is a methyl, fluoromethyl, methoxymethyl, acetoxymethyl, hydroxymethyl or methylene group; R2 is a H atom, a lower alkyl group or a pharmaceutically acceptable cation and an ester of a prodrug; R3 is a H atom or halogen atom; R4 is a H atom, lower alkyl group, a fluoromethyl group, a trifluoromethyl group or F atom; R5 is a H atom or F atom. With the proviso that when R1 is a methyl group, R3 is a F atom then one of the groups represented by R2, R4 and R5 is other than a hydrogen atom. The derivatives of formula (I) are used for the manufacture of medicaments for treatment of bacterial infections
Patent NZ-536298-A (NZ)
Title: The use of melatonin in the manufacture of a medicament for a short-term hypnotic effect wherein the melatonin increases the effect of a GABA-A compound.
Inventor: ZISAPEL NAVA
IPC: A61K47/32
Filed: 2003-03-20
Abstract: Disclosed is the use of melatonin in the manufacture of a medicament for the short-term potentiation of the hypnotic effect in a human. The medicament comprises at least one compound selected from the group consisting of non-barbituate and non-benzodiazepine hypnotics which are GABA-A receptor modulators, provided that the medicament includes an amount of melatonin effective for potentiation of the hypnotic effect of at least one compound when administered to a human in an amount which, if administered in the absence of melatonin, would be sub-therapeutic.
Patent NZ-537749-A (NZ)
Title: Bioreactors and cryopreservation
Inventor: REID LOLA M
IPC: A61P1/16
Filed: 2005-01-18
Abstract: A method of cryopreservation of adherent cells comprising the steps of (a) providing adherent cells in an intracellular matrix or in a culture medium comprising a viscosity enhancer; (b) suspending the cells in a cryopreservation mixture comprising culture medium, an ice-crystal inhibitor, a carbohydrate regulating factor, an iron donor, a lipoprotein and a lipid; and (c) cooling the suspension to below the freezing point of the cells. (62) Divided Out of 531720
Patent NZ-540286-A (NZ)
Title: Waste container apparatus
Inventor: WEBSTER YVONNE JEAN
Filed: 2005-05-25
Abstract: A waste container apparatus (1) is described. The waste container apparatus is adapted and constructed to collect non-fluid waste while allowing fluid waste to enter a waste water disposal system. The waste container apparatus comprises an outer container and an inner container, an inlet adapted to direct fluid and non-fluid waste from outside the apparatus into the inner container, and an outlet adapted to direct fluid waste away from the apparatus, wherein the inner container includes one or more apertures adapted to in use allow fluid waste to pass therethrough into the outer container while substantially capturing non-fluid waste within the inner container and means to allow removal of the non-fluid waste captured therein. The waste apparatus is of particular use in collecting waste from a kitchen sink.
Patent NZ-548086-A (NZ)
Title: Nanoparticle compositions of water-soluble drugs for oral administration and preparation methods thereof
Inventor: PAI CHAUL-MIN
IPC: A61K9/14
Filed: 2004-12-24
Abstract: Disclosed is an orally administrable composition containing nanoparticles with the particle size of 500 nm or less, comprising 0.130 weight% of a complex of a water-soluble drug and a counter-ion substance. The charged water-soluble drug is bonded with the counter-ion substance, 0.5-80 weight% of a lipid, 0.5-80 weight% of a polymer, and 1-80 weight% of an emulsifier. The weight ratio of said lipid and said polymer is in the range of 1:0.053. Also disclosed is a preparation method for this composition. The composition has high gastrointestinal absorption rate upon oral administration, and has high drug entrapping rate in the nanoparticle, and is also stable against lipases.
Patent NZ-549339-A (NZ)
Title: A ladder immobilizer panel for preventing access to the rungs of a ladder
Inventor: SOMERVILLE JUDITH ANN
Filed: 2006-08-18
Abstract: A ladder immobilizer for preventing the use of rungs on a ladder, includes a rigid panel 1, and a substantially flexible engagement means 4, 14 for connecting the panel to the ladder. The panel may be made from firm fabric, plastic, cardboard, foam, metal or wood.
Patent NZ-552985-A (NZ)
Title: Plant disease/pest resistance and defence response facilitated with glucanases from Lolium
Inventor: SPANGENBERG GERMAN
IPC: A01H1/00
Filed: 2004-02-11
Abstract: Described are nucleic acids and nucleic acid fragments encoding amino acid sequences for glucanases from a ryegrass (Lolium) species and the use thereof for modification of plant defence response, disease and/or pest resistance, manipulation of glucan breakdown in plants, production of signals and elicitors for the manipulation of plant development, and/or host defence reaction in plants.
Patent NZ-553816-A (NZ)
Title: Highchair with adjustable seat
Inventor: DRIESSEN FRANCISCUS JOHANNES CORNELIS
IPC: A47C3/28
Filed: 2005-09-15
Abstract: The disclosure relates to a highchair with adjustable seat, comprising a frame and support means which are connected to the frame and which form a bearing plane for supporting the frame on a floor. The disclosure is characterized in that the frame comprises at least two substantially parallel uprights which in a position of use of the chair protrude at least partly obliquely above the bearing plane, and wherein the highchair further comprises a part adjustable along the uprights, which is provided with engaging means for engaging the two uprights, wherein the engaging means has at least one receiving chamber for engaging part of the way round the upright.
Patent NZ-556704-A (NZ)
Title: Instant online lottery method and system
Inventor: WRIGHT ROBERT J
IPC: A63F1/00
Filed: 2005-12-21
Abstract: An instant online lottery game unit to offer an instant online lottery game to a player comprises a price selection input that receives a selection of an instant online lottery ticket price at which an instant online lottery ticket is to be purchased; a communication controller that receives an instant online lottery number and a plurality of game-play combinations from a server and an instant online lottery processor configured to compare the instant online lottery number with each game-play combination in the plurality of game-play combinations after the instant online lottery number and the plurality of game-play combinations is received from the server and before the player is provided with the instant online lottery number and the plurality of game-play combinations. The instant online lottery ticket price is selected from a plurality of instant online lottery ticket prices. Each of the instant online lottery ticket prices corresponds to a distinct known percentage of a progressive jackpot which increases in size based on a portion of ticket sales revenue and that can be won with one of a plurality of game-play combinations. The instant online lottery number is generated by a first random number generator at the server. The plurality of game-play combinations are generated by a second random number generator at the server. The instant online lottery number and the plurality of game-play combinations are provided to the player at the time of purchase of the instant online lottery ticket. The instant online lottery processor calculates a distribution of the progressive jackpot to the player based upon the distinct known percentage associated with the instant online lottery ticket price selected by the player if the instant online lottery number matches in full anyone of the plurality of game-play combinations.
Patent NZ-556753-A (NZ)
Title: System and method(s) of mine planning, design and processing
Inventor: FROYLAND GARY ALLEN
IPC: E21C41/26
Filed: 2003-10-02
Abstract: A method of determining extraction of material from a mine having at least one pit is disclosed. The method comprises the steps of: (a) using a block model to divide the pit into a plurality of blocks based on predetermined mining parameters, (b) defining a plurality of clusters, each comprising a plurality of blocks, (c) defining a plurality of cones, each containing at least one cluster, (d) defining a plurality of clumps by the intersection of cones, (e) determining a secondary clustering of the blocks in the block order extraction schedule, the secondary clustering, clustering blocks according to spatial order and block order extraction schedule ordering, (f) propagating second cones upwardly from each secondary cluster of blocks, and (g) ordering the extraction of material from each second cone to provide an optimal extraction schedule of all blocks in the pit.
Patent NZ-575636-A (NZ)
Title: An improved process for the preparation of temozolomide and analogs
Inventor: SRINIVAS PATHI L
IPC: A61P35/00
Filed: 2007-09-28
Abstract: Disclosed herein is a process for isolating 3-methyl-8-aminocarbonyl-imidazo[5,1-d]-1,2,3,5-terazin-4(3H)-one (temozolomide)comprising diazotizing a compound of formula IIA, wherein R=CH3, in the presence of at least one metal halide, an acid and a source of nitrous acid, wherein the diazotization proceeds by the addition of the compound of formula IIA and the metal halide to a solution containing the source of nitrous acid and subjecting the acidic solution of temozolomide to a counter-current continuous liquid-liquid extraction using water immiscible solvent.
Patent NZ-578096-A (NZ)
Title: 5-pyridinone substituted indazoles
Inventor: SURMAN MATTHEW DAVID
IPC: C07D498/08
Filed: 2008-01-09
Abstract: Disclosed are 5-pyridinone substituted indazole compounds of formula I as depicted, wherein the substituents are as defined in the specification, and their use in treating obesity, anxiety, depression, non-alcoholic fatty liver disease and a disease or condition which is susceptible to MCH1 receptor modulation.
Patent NZ-588239-A (NZ)
Title: Capsule for the prevention of cardiovascular diseases
Inventor: GUERRERO MARTA
IPC: A61K31/405
Filed: 2009-03-25
Abstract: Disclosed is a capsule which comprises: (i) 1 or 2 coated tablet(s) comprising acetylsalicylic; (ii) 1 or 2 coated tablet(s) comprising simvastatin or 1 or 2 coated tablet(s) comprising pravastatin or a pharmaceutically acceptable salt thereof; and (iii) 1, 2 or 3 coated tablet(s) comprising lisinopril or a hydrated form, 1, 2 or 3 coated tablet(s) comprising ramipril, or 1, 2 or 3 coated tablet(s) comprising perindopril or a pharmaceutically acceptable salt thereof, The amount of acetylsalcilic acid is from 40.5 to 200 mg. The amount of simvastatin or pravastatin is from 20 to 80 mg. The amount of lisinopril, ramipril or perindopril is from 5 to 40 mg, 2.5 to 20 mg or 2 to 16 mg respectively. The acetylsalicylic acid tablets are coated with a partially hydrolysed polyvinyl alcohol comprising film. The simvastatin tablets are coated with a hydroxypropylmethyl cellulose comprising film. The pravastatin or pharmaceutically acceptable salt tablets are coated with a hydroxypropylmethyl cellulose comprising film. The lisinopril or hydrated form tablets are coated with a partially hydrolysed polyvinyl alcohol comprising film. The ramipril tablets are coated with a partially hydrolysed polyvinyl alcohol comprising film. The perindopril or pharmaceutically acceptable salt tablets are coated with a partially hydrolysed polyvinyl alcohol comprising film. Also disclosed is the use of the capsule in the manufacture of a medicament for the prevention of cardiovascular diseases in high risk populations.
Patent NZ-590724-A (NZ)
Title: A method of brewing beer in a disk stack centrifuge
Inventor: BOERESCU ALINA
IPC: C12H1/06
Filed: 2009-06-29
Abstract: A method of brewing beer including the steps of fermenting wort in a fermenter, and centrifuging the fermented wort by means of a disc stack centrifuge. The fermenter is a batch fermenter and that the ratio of the Sigma-factor and the flow rate of the centrifuging step is at least 400 m2hr/hl.